What iProcess Global Research does

iProcess Global Research is a private, for-profit medical company headquartered in Dallas, United States, founded in 2004. The firm operates with a headcount of 11-50 employees and positions itself as a provider of three integrated service lines: biospecimens, laboratory testing, and artificial intelligence services. Its stated end markets appear to be healthcare and life-sciences research clients seeking a combined supplier of biological samples, diagnostic or research testing capacity, and AI-driven analytics — though specific customer segments, named accounts, pricing, and contract structures are not disclosed in the available source material.

The company's service mix is unusual for a firm of its size in that it spans physical biospecimen supply, wet-lab testing, and software/AI capabilities, suggesting a vertically integrated offering in which sample-derived data may feed downstream algorithmic products. Operating a physical biospecimen and testing capability alongside AI tooling implies the firm could derive recurring, data-rich revenue if execution is strong. No technology stack details, proprietary models, certifications (e.g., CLIA, CAP, ISO), partnerships, or leadership profiles are available in the source data to substantiate technical depth, accreditation status, or commercial maturity.

Available public disclosure is thin: the company's website (iprocess.net) returns only a loading/verification page, and most third-party firmographic fields — including revenue, funding history, customer logos, headcount trends, office locations, awards, and management team — are unpopulated. The 20-year operating history at a modest, steady headcount of 11-50 is consistent with a bootstrapped, niche specialty-services firm rather than a venture-backed high-growth enterprise, but the absence of verifiable revenue, hiring, or strategic-move signals limits any confident growth or scale classification.

Name

iProcess Global Research

Website

https://iprocess.net

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

iProcess Global Research is a Dallas-based private medical company founded in 2004 that provides biospecimens, laboratory testing, and artificial intelligence services to healthcare and life-sciences research clients, operating with 11-50 employees.

Ownership category

akta.pro rank

Product category

Medical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical Laboratories (621511), Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836), Services-Testing Laboratories (8734)

akta.pro primary industry

Industry & Sector Research (Syndicated/Custom) (BPAHALAE)

akta.pro secondary industry

Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)

Keywords

• Medical research services
• Biospecimen supply
• Clinical testing services
• AI medical research
• Biomedical specimens

Headquarters

HQ city

Dallas

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Core offering

iProcess Global Research is a medical company that provides biospecimens, testing, and artificial intelligence services. Its core activity is supplying biological specimens and laboratory testing alongside AI-enabled research support for medical, clinical, and life-science applications.

Differentiator

Problem solved

Functional benefit

Products and services

• Biospecimen Supply Supply of biological specimens for medical, clinical, pharmaceutical, and academic research customers.
• Clinical and Laboratory Testing Services Testing services supporting medical research and clinical applications for pharmaceutical, biotech, and research clients.
• Artificial Intelligence Research Services AI-enabled services delivered to medical research customers to support analytical and research workflows.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Emerging players

• Tempus AI: AI-driven precision medicine company combining multi-modal patient data with molecular testing. Relevant comparator for iProcess's AI-services thesis and as a benchmark for the data-plus-biomaterial business model.

Broad incumbents

• Medidata Solutions (Dassault Systèmes): Clinical trial technology and analytics platform with AI capabilities across life sciences R&D. Comparable on the AI-for-clinical-research axis and as a potential ecosystem partner for iProcess's data layer.
• Azenta Life Sciences (Brooks Life Sciences): Large-scale provider of sample management, biorepository, and genomic services for life sciences. A broader incumbent in the same biospecimen and sample logistics category where iProcess competes.
• Quest Diagnostics: Large clinical diagnostics and testing provider serving providers, biopharma, and consumers. An incumbent benchmark for iProcess's laboratory testing services and a potential reference lab partner or competitor.
• Veeva Systems: Life sciences cloud and data platform spanning clinical, regulatory, and commercial with growing AI/analytics capabilities. Adjacent incumbent benchmark for how data and AI platforms are monetized in life sciences.
• Labcorp (Labcorp Drug Development / Fortrea): Global clinical and bioanalytical laboratory network with central labs, specialty testing, and bioanalytical services. Competes with iProcess on the testing side and sets buyer expectations around scale, accreditation, and turnaround.

Direct peers

• Discovery Life Sciences: Integrated biospecimen and bioanalytic services provider offering tissue, blood, and cellular products with lab and bioinformatics support. Overlaps iProcess on biospecimens + testing + data analytics and competes for the same translational research buyers.
• Indivumed: Specializes in high-quality human tissue biospecimens and multi-omics analytics for oncology research. Highly comparable on biospecimen-plus-AI/data-services orientation and customer base in translational oncology.
• Cureline: Clinical biospecimen provider with global sourcing networks and translational research services. Comparable niche scale and service mix to iProcess, targeting the same pharma and diagnostic buyers.
• BioIVT: Global supplier of biospecimens and research services to pharma and diagnostics. Directly comparable to iProcess's biospecimen and testing core, with a similar buyer profile of biotech, academic, and diagnostic customers.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/iprocessglobal
• LinkedInlinkedin.com/company/iprocessglobal

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iProcess Global Research